CANCER 2026 Emmy Dolman
Children's Cancer Institute, NSW, Australia
Presentations this author is a contributor to:
Ex Vivo Drug Efficacy in High-Risk Paediatric Cancers: A Comprehensive Analysis of the ZERO Cohort (#150)
5:40 PM
Luke LF Fuller
Welcome Reception & Poster Session 1